Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEUL
Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ
FEUL
|
+$302M |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$273M |
| 3 |
Petrobras
PBR
|
+$272M |
| 4 |
BHP
BHP
|
+$266M |
| 5 |
Freeport-McMoran
FCX
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$460M |
| 2 |
FIEU
FI Enhanced Europe 50 ETN
FIEU
|
+$267M |
| 3 |
FLEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series B
FLEU
|
+$239M |
| 4 |
HDFC Bank
HDB
|
+$227M |
| 5 |
Comcast
CMCSA
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.36% |
| 2 | Technology | 15.02% |
| 3 | Healthcare | 11.86% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Consumer Staples | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFN
151
DELISTED
Infinera Corporation Common Stock
INFN
| $59.2M | 0.08% |
5,966,448
+37,172
| +0.6% | +$387K |
|
152
Vanguard FTSE Europe ETF
VGK
$30.8B
| $58.7M | 0.08% |
1,045,226
+73,101
| +8% | +$4.3M |
|
153
iShares MSCI Europe Financials ETF
EUFN
$4.14B
| $57.6M | 0.07% |
2,847,145
+225,448
| +9% | +$5.08M |
|
|
ETFC
154
DELISTED
E*Trade Financial Corporation
ETFC
| $57M | 0.07% |
931,872
-51,791
| -5% | -$3.21M |
|
155
Core Laboratories
CLB
$477M
| $56.9M | 0.07% |
450,685
+12,671
| +3% | +$1.54M |
|
|
CAVM
156
DELISTED
Cavium, Inc.
CAVM
| $56.9M | 0.07% |
657,375
-220,394
| -25% | -$17.7M |
|
157
Regal Rexnord
RRX
$13.5B
| $56.6M | 0.07% |
692,220
-7,318
| -1% | -$566K |
|
|
MZTI
158
The Marzetti Company
MZTI
$2.95B
| $56.4M | 0.07% |
407,441
-1,139
| -0.3% | -$146K |
|
159
Stratasys
SSYS
$697M
| $56.4M | 0.07% |
2,945,966
-38,755
| -1% | -$765K |
|
|
INVX
160
Innovex International
INVX
$1.85B
| $55.8M | 0.07% |
1,085,527
+346,745
| +47% | +$16.2M |
|
|
CADE
161
DELISTED
Cadence Bank
CADE
| $55.5M | 0.07% |
1,683,021
-122,977
| -7% | -$4.11M |
|
162
Helmerich & Payne
HP
$3.37B
| $55.3M | 0.07% |
866,857
+22,457
| +3% | +$1.53M |
|
163
Diageo
DEO
$49.5B
| $55.1M | 0.07% |
382,433
+3,156
| +0.8% | +$452K |
|
164
MKS Inc
MKSI
$19.8B
| $55M | 0.07% |
574,609
-34,672
| -6% | -$3.78M |
|
|
PC
165
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
| $54.1M | 0.07% |
4,014,975
+158,521
| +4% | +$2.14M |
|
166
Artisan Partners
APAM
$2.82B
| $52.5M | 0.07% |
1,742,814
-13,834
| -0.8% | -$449K |
|
167
Prestige Consumer Healthcare
PBH
$2.37B
| $51.9M | 0.07% |
1,352,880
-12,996
| -1% | -$438K |
|
168
Southern Copper
SCCO
$145B
| $51.3M | 0.07% |
+1,181,437
| New | +$56.7M |
|
169
Cemex
CX
$17.2B
| $49.8M | 0.06% |
7,588,376
+14,546
| +0.2% | +$92K |
|
170
iShares MSCI Japan ETF
EWJ
$22.1B
| $49.6M | 0.06% |
855,779
+4,060
| +0.5% | +$245K |
|
|
JHG
171
DELISTED
Janus Henderson
JHG
| $49.3M | 0.06% |
1,603,621
-5,531
| -0.3% | -$177K |
|
172
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $49.3M | 0.06% |
1,633,863
+100,904
| +7% | +$3.04M |
|
173
PayPal
PYPL
$49.3B
| $48.4M | 0.06% |
581,461
+25,485
| +5% | +$2.03M |
|
174
Darling Ingredients
DAR
$9.69B
| $48.4M | 0.06% |
2,432,920
+53,592
| +2% | +$971K |
|
|
LUX
175
DELISTED
Luxottica Group
LUX
| $48.3M | 0.06% |
747,939
-64
| -0% | -$4.13K |
|
Similar funds
Ken Fisher's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Fisher held 924 positions worth $77B, up 2.1% from $75.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q2 2018 filing shows 95 new, 298 increased, 389 reduced and 62 closed positions. Its largest new stake was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M. The largest sale was Amazon, an estimated $460M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q2 2018 buy was Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ: 3,218,864 shares worth $294M.
- Ken Fisher added most to Barclays ETN+ FI Enhanced Europe 50 ETN Series C in Q2 2018, an estimated $273M increase.
- Ken Fisher's biggest Q2 2018 reduction was Amazon, cutting an estimated $460M.
- Ken Fisher fully exited Dr. Reddy's Laboratories in Q2 2018, selling an estimated $165M.
- Ken Fisher's ten largest holdings make up 26% of its $77B portfolio in Q2 2018.
- Ken Fisher opened 95 new positions and closed 62 in Q2 2018.
- Ken Fisher's portfolio value rose 2.1% quarter-over-quarter to $77B.
Based on Fisher Asset Management's 13F filing for Q2 2018, filed 9 Jul 2018.